EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 31 / No 5 (Mai 2015) Med Sci (Paris), 31 5 (2015) 493-498 References
Free Access
Issue
Med Sci (Paris)
Volume 31, Number 5, Mai 2015
Page(s) 493 - 498
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20153105010
Published online 09 June 2015
  1. Wittamer V, Franssen JD, Vulcano M, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med 2003 ; 198 : 977–985. [CrossRef] [PubMed] [Google Scholar]
  2. Zhao L, Yamaguchi Y, Sharif S, et al. Chemerin158K protein is the dominant chemerin isoform in synovial and cerebrospinal fluids but not in plasma. J Biol Chem 2011 ; 286 : 39520–39527. [CrossRef] [PubMed] [Google Scholar]
  3. Stejskal D, Karpisek M, Hanulova Z, Svestak M. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population: a pilot study. Biomed Pap Med Fac 2008 ; 152 : 217–221. [CrossRef] [Google Scholar]
  4. Zabel BA, Allen SJ, Kulig P, et al. Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades. J Biol Chem 2005 ; 280 : 34661–34666. [CrossRef] [PubMed] [Google Scholar]
  5. Hansen IR, Jansson KM, Cannon B, et al. Contrasting effects of cold acclimation versus obesogenic diets on chemerin gene expression in brown and brite adipose tissues. Biochim Biophys Acta 2014 ; 1841 : 1691–1699. [CrossRef] [PubMed] [Google Scholar]
  6. Du XY, Leung LL. Proteolytic regulatory mechanism of chemerin bioactivity. Acta Biochim Biophys Sin (Shanghai) 2009 ; 41 : 973–979. [CrossRef] [PubMed] [Google Scholar]
  7. Mattern A, Zellmann T, Beck-Sickinger AG. Processing, signaling, and physiological function of chemerin. IUBMB Life 2014 ; 66 : 19–26. [CrossRef] [PubMed] [Google Scholar]
  8. Fatima SS, Rehman R, Baig M, et al. New roles of the multidimensional adipokine: chemerin. Peptides 2014 ; 62 : 15–20. [CrossRef] [PubMed] [Google Scholar]
  9. Parolini S, Santoro A, Marcenaro E, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007 ; 109 : 3625–3632. [CrossRef] [PubMed] [Google Scholar]
  10. Goralski KB, McCarthy TC, Hanniman EA, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007 ; 282 : 28175–28188. [CrossRef] [PubMed] [Google Scholar]
  11. Sell H, Laurencikiene J, Taube A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009 ; 58 : 2731–2740. [CrossRef] [PubMed] [Google Scholar]
  12. Becker M, Rabe K, Lebherz C, et al. Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. Diabetes 2010 ; 59 : 2898–2903. [CrossRef] [PubMed] [Google Scholar]
  13. Kaur J, Adya R, Tan BK, et al. Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun 2010 ; 39 : 1762–1768. [CrossRef] [Google Scholar]
  14. Marchese A, Docherty JM, Nguyen T, et al. Cloning of human genes encoding novel G-protein-coupled receptors. Genomics 1994 ; 23 : 609–618. [CrossRef] [PubMed] [Google Scholar]
  15. Shimizu N, Soda Y, Kanbe K, et al. An orphan G protein-coupled receptor, GPR1, acts as a coreceptor to allow replication of human immunodeficiency virus types 1 and 2 in brain-derived cells. J Virol 1999 ; 73 : 5231–5239. [PubMed] [Google Scholar]
  16. Barnea G, Strapps W, Herrada G, et al. The genetic design of signaling cascades to record receptor activation. Proc Natl Acad Sci USA 2008 ; 105 : 64–69. [CrossRef] [Google Scholar]
  17. Yoshimura T, Oppenheim JJ. Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties. Exp Cell Res 2011 ; 317 : 674–684. [CrossRef] [PubMed] [Google Scholar]
  18. Zabel BA, Nakae S, Zuniga L, et al. Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis. J Exp Med 2008 ; 205 : 2207–2220. [CrossRef] [PubMed] [Google Scholar]
  19. Monnier J, Lewen S, O’Hara E, et al. Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells. J Immunol 2012 ; 189 : 956–967. [CrossRef] [PubMed] [Google Scholar]
  20. Ha YJ, Kang EJ, Song JS, et al. Plasma chemerin levels in rheumatoid arthritis are correlated with disease activity rather than obesity. Joint Bone Spine 2014 ; 81 : 189–190. [CrossRef] [PubMed] [Google Scholar]
  21. Bozaoglu K, Bolton K, McMillan J, et al. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007 ; 148 : 4687–4694. [CrossRef] [PubMed] [Google Scholar]
  22. Weigert J, Neumeier M, Wanninger J, et al. Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf) 2010 ; 72 : 342–348. [CrossRef] [PubMed] [Google Scholar]
  23. Parlee SD, Ernst MC, Muruganandan S, et al. Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-alpha. Endocrinology 2010 ; 151 : 2590–2602. [CrossRef] [PubMed] [Google Scholar]
  24. Ernst MC, Sinal CJ. Chemerin: at the crossroads of inflammation and obesity. Trends Endocrinol Metab 2010 ; 21 : 660–667. [CrossRef] [PubMed] [Google Scholar]
  25. Roh SG, Song SH, Choi KC, et al. Chemerin: a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007 ; 362 : 1013–1018. [CrossRef] [PubMed] [Google Scholar]
  26. Rabe K1, Lehrke M, Parhofer KG, et al. Adipokines and insulin resistance. Mol Med 2008; 14 : 741–751. [PubMed] [Google Scholar]
  27. Ernst MC, Haidl ID, Zuniga LA, et al. Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance. Endocrinology 2012; 153 : 672–682. [CrossRef] [PubMed] [Google Scholar]
  28. Rouger L, Denis GR, Luangsay S, et al. ChemR23 knockout mice display mild obesity but no deficit in adipocyte differentiation. J Endocrinol 2013; 219 : 279–289. [CrossRef] [PubMed] [Google Scholar]
  29. Rourke JL, Muruganandan S, Dranse HJ, et al. Gpr1 is an active chemerin receptor influencing glucose homeostasis in obese mice. J Endocrinol 2014 ; 222 : 201–215. [CrossRef] [PubMed] [Google Scholar]
  30. Kralisch S, Weise S, Sommer G, et al. Interleukin-1beta induces the novel adipokine chemerin in adipocytes in vitro. Regul Pept 2009 ; 154 : 102–106. [CrossRef] [PubMed] [Google Scholar]
  31. Suzuki Y, Hong YH, Song SH, et al. The regulation of chemerin and CMKLR1 genes expression by TNF-alpha, adiponectin, and chemerin analog in bovine differentiated adipocytes. Asian-Australas J Anim Sci 2012 ; 25 : 1316–1321. [CrossRef] [PubMed] [Google Scholar]
  32. Zabel BA, Kwitniewski M, Banas M, et al. Chemerin regulation and role in host defense. Am J Clin Exp Immunol 2014 ; 3 : 1–19. [PubMed] [Google Scholar]
  33. Muruganandan S, Parlee SD, Rourke JL, et al. Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis. J Biol Chem 2011 ; 286 : 23982–23995. [CrossRef] [PubMed] [Google Scholar]
  34. Bauer S, Wanninger J, Schmidhofer S, et al. Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology 2011 ; 152 : 26–35. [CrossRef] [PubMed] [Google Scholar]
  35. Muruganandan S, Roman AA, Sinal CJ. Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. J Bone Miner Res 2010 ; 25 : 222–234. [CrossRef] [PubMed] [Google Scholar]
  36. Tan BK, Chen J, Farhatullah S, et al. Insulin and metformin regulate circulating and adipose tissue chemerin. Diabetes 2009 ; 58 : 1971–1977. [CrossRef] [PubMed] [Google Scholar]
  37. Reverchon M, Cornuau M, Rame C, et al. Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells. Hum Reprod 2012 ; 27 : 1790–1800. [CrossRef] [PubMed] [Google Scholar]
  38. Reverchon M, Bertoldo MJ, Rame C, et al. Chemerin (RARRES2) decreases in vitro granulosa cell steroidogenesis and blocks oocyte meiotic progression in bovine species. Biol Reprod 2014 ; 90 : 102. [CrossRef] [PubMed] [Google Scholar]
  39. Wang Q, Kim JY, Xue K, et al. Chemerin, a novel regulator of follicular steroidogenesis and its potential involvement in polycystic ovarian syndrome. Endocrinology 2012 ; 153 : 5600–5611. [CrossRef] [PubMed] [Google Scholar]
  40. Kim JY, Xue K, Cao M, et al. Chemerin suppresses ovarian follicular development and its potential involvement in follicular arrest in rats treated chronically with dihydrotestosterone. Endocrinology 2013 ; 154 : 2912–2923. [CrossRef] [PubMed] [Google Scholar]
  41. March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010 ; 25 : 544–551. [CrossRef] [PubMed] [Google Scholar]
  42. Guzel EC, Celik C, Abali R, et al. Omentin and chemerin and their association with obesity in women with polycystic ovary syndrome. Gynecol Endocrinol 2014 ; 30 : 419–422. [CrossRef] [PubMed] [Google Scholar]
  43. Wang Q, Leader A, Tsang BK. Inhibitory roles of prohibitin and chemerin in FSH-induced rat granulosa cell steroidogenesis. Endocrinology 2013 ; 154 : 956–967. [CrossRef] [PubMed] [Google Scholar]
  44. Li L, Ma P, Huang C, et al. Expression of chemerin and its receptors in rat testes and its action on testosterone secretion. J Endocrinol 2014 ; 220 : 155–163. [CrossRef] [PubMed] [Google Scholar]
  45. Li L, Huang C, Zhang X, et al. Chemerin-derived peptide C-20 suppressed gonadal steroidogenesis. Am J Reprod Immunol 2014 ; 71 : 265–277. [CrossRef] [PubMed] [Google Scholar]
  46. D’Ippolito S, Tersigni C, Scambia G, et al. Adipokines, an adipose tissue and placental product with biological functions during pregnancy. Biofactors 2012 ; 38 : 14–23. [CrossRef] [PubMed] [Google Scholar]
  47. Noureldeen AF, Qusti SY, Al-Seeni MN, et al. Maternalleptin, adiponectin, resistin, visfatin and tumor necrosis factor-alpha in normal and gestational diabetes. Indian J Clin Biochem 2014 ; 29 : 462–470. [CrossRef] [PubMed] [Google Scholar]
  48. Kasher-Meron M, Mazaki-Tovi S, Barhod E, et al. Chemerin concentrations in maternal and fetal compartments: implications for metabolic adaptations to normal human pregnancy. J Perinat Med 2014 ; 42 : 371–378. [CrossRef] [PubMed] [Google Scholar]
  49. Garces MF, Sanchez E, Acosta BJ, et al. Expression and regulation of chemerin during rat pregnancy. Placenta 2012 ; 33 : 373–378. [CrossRef] [PubMed] [Google Scholar]
  50. Garces MF, Sanchez E, Ruiz-Parra AI, et al. Serum chemerin levels during normal human pregnancy. Peptides 2013 ; 42 : 138–143. [CrossRef] [PubMed] [Google Scholar]
  51. Duan DM, Niu JM, Lei Q, et al. Serum levels of the adipokine chemerin in preeclampsia. J Perinat Med 2011 ; 40 : 121–127. [PubMed] [Google Scholar]
  52. Reverchon M, Ramé C, Bertoldo M, Dupont J. Adipokines and the female reproductive tract. Int J Endocrinol 2014 ; 2014 : 232454. [CrossRef] [PubMed] [Google Scholar]
  53. Foretz M, Viollet B. Les nouvelles promesses de la metformine. Med Sci (Paris) 2014 ; 30 : 82–92. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  54. Rigourd V, Chelbi ST, Vaiman D. La pré-éclampsie. Med Sci (Paris) 2008 ; 24 : 1017–1019. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.